IRIS Institutional Research Information System - OPENBS Open Archive UniBS

MAGRINI, STEFANO MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.155
EU - Europa 6.808
AS - Asia 3.738
AF - Africa 25
Continente sconosciuto - Info sul continente non disponibili 23
SA - Sud America 18
OC - Oceania 12
Totale 24.779
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.110
CN - Cina 2.298
UA - Ucraina 2.294
DE - Germania 1.138
IT - Italia 859
HK - Hong Kong 799
FI - Finlandia 539
IE - Irlanda 539
PL - Polonia 488
SG - Singapore 414
FR - Francia 378
GB - Regno Unito 286
SE - Svezia 99
IN - India 81
VN - Vietnam 56
RU - Federazione Russa 47
CZ - Repubblica Ceca 42
TR - Turchia 37
CA - Canada 36
BE - Belgio 28
EU - Europa 23
NL - Olanda 23
JP - Giappone 14
GR - Grecia 13
AU - Australia 10
BR - Brasile 9
ID - Indonesia 6
IR - Iran 6
MA - Marocco 6
MU - Mauritius 6
CH - Svizzera 5
MX - Messico 5
AR - Argentina 4
IL - Israele 4
MK - Macedonia 4
UG - Uganda 4
AT - Austria 3
BD - Bangladesh 3
EG - Egitto 3
KR - Corea 3
LA - Repubblica Popolare Democratica del Laos 3
RO - Romania 3
TN - Tunisia 3
AZ - Azerbaigian 2
BO - Bolivia 2
DK - Danimarca 2
HU - Ungheria 2
KH - Cambogia 2
LV - Lettonia 2
MD - Moldavia 2
MY - Malesia 2
NZ - Nuova Zelanda 2
PE - Perù 2
PT - Portogallo 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
TH - Thailandia 2
AM - Armenia 1
BG - Bulgaria 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CL - Cile 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ES - Italia 1
IS - Islanda 1
JM - Giamaica 1
KG - Kirghizistan 1
KW - Kuwait 1
NO - Norvegia 1
RS - Serbia 1
SI - Slovenia 1
SL - Sierra Leone 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 24.779
Salva come PNG Salva come JPEG
Città #
Jacksonville 1.777
Fairfield 1.744
Woodbridge 1.608
Houston 1.138
Ashburn 992
Ann Arbor 899
Princeton 806
Chandler 803
Hong Kong 794
Cambridge 772
Wilmington 696
Seattle 676
Nanjing 578
Dublin 536
Warsaw 486
New York 310
Beijing 305
Dearborn 268
Singapore 252
Helsinki 232
Nanchang 217
Des Moines 178
Changsha 136
Shenyang 134
Milan 129
Brescia 127
Hebei 125
San Diego 120
Jinan 111
Tianjin 106
Shanghai 101
Jiaxing 88
Kunming 63
Verona 62
Dong Ket 56
Hangzhou 50
Boardman 49
Washington 46
Rome 41
Los Angeles 40
Brno 37
Lancaster 36
London 33
Ningbo 32
Lanzhou 31
San Francisco 29
Taizhou 29
Zhengzhou 29
Norwalk 28
Brussels 27
Munich 25
Augusta 24
Kocaeli 24
Haikou 22
Orange 22
Pune 22
Changchun 21
Guangzhou 20
Toronto 17
Nürnberg 16
Taiyuan 16
Ceto 15
Redwood City 14
Athens 13
Hefei 11
San Mateo 11
Tokyo 11
Dresden 10
Edmonton 10
Fuzhou 9
Chiswick 8
Gunzenhausen 8
Iseo 8
Kilburn 8
Amsterdam 7
Bologna 6
Hanover 6
Hounslow 6
Isorella 6
Monza 6
Mountain View 6
Parma 6
Ardabil 5
Cazzago San Martino 5
Leawood 5
Phoenix 5
Rozzano 5
Bergamo 4
Berlin 4
Chicago 4
Chongqing 4
Cremona 4
Cuernavaca 4
Delhi 4
Falkenstein 4
Falls Church 4
Florence 4
Frankfurt am Main 4
Lappeenranta 4
Melbourne 4
Totale 18.453
Salva come PNG Salva come JPEG
Nome #
Low dose rate brachytherapy (LDR-BT) as monotherapy for early stage prostate cancer in Italy: practice and outcome analysis in a series of 2237 patients from 11 institutions 205
Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: the Pros-IT CNR study 200
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial 194
Light and shadows of a new technique: Isphoton total-skin irradiation using helical IMRT feasible, less complex and as toxic as the electrons one? 178
Biological effect of neoadjuvant androgen-deprivation therapy assessed on specimens from radical prostatectomy: a systematic review 162
Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study 156
From chemotherapy to target therapies associated with radiation in the treatment of NSCLC: a durable marriage? 153
Resected pN1 non-small cell lung cancer: recurrence patterns and nodal risk factors may suggest selection criteria for post-operative radiotherapy 152
Pros-IT CNR: an Italian prostate cancer monitoring project 147
Post-surgical therapeutic approaches to glioblastoma patients submitted to biopsy (BA) or "partial" resection (PR): the possibilities to treat also them without renunciations. Study from the Brescia Neuro-Oncology Group 144
Reirradiation in head and neck recurrent or second primary tumor: efficacy, safety, and prognostic factors 144
In reply to Borras et al. the strengthening of Radiation Oncologist role inside multidisciplinary arena within 2025 142
Cetuximab and Radiotherapy Versus Cisplatin and Radiotherapy for Locally Advanced Head and Neck Cancer: A Randomized Phase II Trial 140
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Dental pathologies and osteoradionecrosis (Part 1) literature review and consensus statement 139
The treatment of patients with 1-3 brain metastases: is there a place for whole brain radiotherapy alone, yet? A retrospective analysis 136
Salvage therapy of small volume prostate cancer nodal failures: A review of the literature 135
A neuro-oncologic challenge: the case of a large, aggressive, malignant meningioma of the skull base with paranasal sinus involvement 135
Clinical outcomes and toxicity after exclusive versus postoperative radiotherapy in supraglottic cancer: new solutions for old problems? The case of stage I and II disease 130
Reply to 'Comment on 'Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study'' 129
THE ROLE OF PRIMARY SURGERY AND EXTERNAL BEAM RADIATION THERAPY IN THE MANAGEMENT OF NON-METASTATIC DUCTAL PROSTATE CANCER: 20-YEAR OUTCOMES FROM A SINGLE INSTITUTION EXPERIENCE 129
Subgroup Analysis According to Human Papillomavirus Status and Tumor Site of a Randomized Phase II Trial Comparing Cetuximab and Cisplatin Combined With Radiation Therapy for Locally Advanced Head and Neck Cancer 127
Oligometastatic prostate cancer patients stratification: A molecular signature identified by liquid biopsy 126
Clinical outcomes and toxicity after exclusive versus postoperative radiotherapy in supraglottic cancer: new solutions for old problems? The case of stage III and IV disease 124
Stereotactic ablative radiation therapy in renal cell carcinoma: From oligometastatic to localized disease. 122
Role of external beam radiotherapy in the treatment of relapsing meningioma 121
Patterns of practice and survival in a retrospective analysis of 1722 adult astrocytoma patients treated between 1985 and 2001 in 12 italian radiation oncology centers 120
Mebendazole as a candidate for drug repurposing in oncology: An extensive review of current literature 119
Hypofractionated radiation therapy versus chemotherapy with temozolomide in patients affected by RPA class V and VI glioblastoma: a randomized phase II trial 119
Carboplatin (JM8), etoposide (VP16) and thoracic Irradiation for small cell lung cancer (S.C.L.C.): An evaluation of lung toxicity 118
Primary cutaneous non-Hodgkin lymphoma: results of a retrospective analysis in the light of the recent ILROG guidelines 118
A benchmark study on 883 nasopharyngeal cancer patients treated in two Italian centres from 1977 to 2000. Part I: evolving technical choices and survival 115
Radiotherapy for adult medulloblastoma: Long term result from a single institution. A review of prognostic factors and why we do need a multi-institutional cooperative program 115
Non-palliative radiotherapy in ab initio oligometastatic prostate cancer: an Italian national survey 114
Clinical and histological prognostic factors of recurrent and/or metastatic salivary gland adenoid cystic carcinoma 113
Whole brain radiotherapy with adjuvant or concomitant boost in brain metastasis: dosimetric comparison between helical and volumetric IMRT technique 113
Effects of fluconazole in the prophylaxis of oropharyngeal candidiasis in patients undergoing radiotherapy for head and neck tumour: results from a double-blind placebo-controlled trial. 112
Circulating tumor cells in patients with recurrent or metastatic head and neck carcinoma: prognostic and predictive significance 112
Adjuvant radiotherapy after extrapleural pneumonectomy for mesothelioma. Prospective analysis of a multi-institutional series 111
Could Concomitant Radio-Chemotherapy Improve the Outcomes of Early-Stage Node Negative Anal Canal Cancer Patients? A Retrospective Analysis of 122 Patients 111
Association between single nucleotide polymorphisms in the XRCC1 and RAD51 genes and clinical radiosensitivity in head and neck cancer 110
Could Machine Learning Improve the Prediction of Pelvic Nodal Status of Prostate Cancer Patients? Preliminary Results of a Pilot Study 110
Adjuvant intensity-modulated proton therapy in malignant pleural mesothelioma 109
Predictive factors for oropharyngeal mycosis during radiochemotherapy for head and neck carcinoma and consequences on treatment duration. Results of mycosis in radiotherapy (MIR): A prospective longitudinal study 109
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Xerostomia and trismus (Part 2). Literature review and consensus statement 109
Optimizing Radiation Treatment Decisions for Patients Who Receive Neoadjuvant Chemotherapy 108
Salvage Low Dose Rate Brachytherapy For Recurrent Prostate Cancer After External Beam Radiotherapy: Results From A Single Institution With Focus On Toxicity And Functional Outcomes 108
Postoperative radiotherapy for prostate cancer: the sooner the better and potential to reduce toxicity even further 108
Extreme hypofractionation for early prostate cancer: Biology meets technology 108
Retreatment of recurrent adult medulloblastoma with radiotherapy: a case report and review of the literature. 108
Changes in patterns of practice for prostate cancer radiotherapy in Italy 1995-2003. A survey of the Prostate Cancer Study Group of the Italian Radiation Oncology Society 107
Pattern of relapse of glioblastoma multiforme treated with radical radio-chemotherapy: Could a margin reduction be proposed? 107
Circulating Tumour Cells in locally advanced head and neck cancer: Preliminary report about their possible role in predicting response to non-surgical treatment and survival. 106
From Molecular to Clinical Radiation Biology of Glioblastoma 106
Open-source, low cost, high-reliability solutions for digital imaging systrems: example of a dicom router/Soluzioni Open Source per sistemi Low Cost e High Reliability per l'imaging digitale: l'esempio di un dicom router. 105
Radiation Tolerance of Normal Brain: QUANTEC 2010 and Beyond 105
Exploiting Machine Learning for Predicting Nodal Status in Prostate Cancer Patients 104
Radiotherapy and Tyrosine Kinase Inhibitors in Stage IV Non-small Cell Lung Cancer: Real-life Experience 104
Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study 103
Glutamine synthetase expression as a valuable marker of epilepsy and longer survival in newly diagnosed glioblastoma multiforme 102
A benchmark study on 883 nasopharyngeal cancer patients treated in two Italian centres from 1977 to 2000. Part II: evolving technical choices and toxicity patterns 101
Analysis of Circulating Tumor Cells in Prostate Cancer Patients at PSA Recurrence and Review of the Literature 101
Which role for radiation therapy in ethmoid cancer? A retrospective analysis of 84 cases from a single Institution 98
Radiotherapy in Small Cell Lung Cancer 98
Information Retrieval in Medicine: an Extensive Experimental Study 98
Association between testicular cancer and spina bifida occulta 97
Stereotactic body radiotherapy for lung oligometastases impacts on systemic treatment-free survival: a cohort study 96
Differential Diagnosis and Clinical Management of a Case of COVID-19 in a Patient With Stage III Lung Cancer Treated With Radio-chemotherapy and Durvalumab 96
The impact of the histology of primary tumor on RPA prognostic classifications in patients (pts) treated for brain metastases (BM). Retrospective analysis of 382 pts treated with hypofractionated whole brain radiotherapy (HWBRT). 93
Interim PET After Two ABVD Cycles in Early-Stage Hodgkin Lymphoma: Outcomes Following the Continuation of Chemotherapy Plus Radiotherapy 93
Nasopharyngeal carcinoma 92
The growing role of biology in the treatment of glioblastoma: no more one kind of disease 92
Merkel Cell Carcinoma: Report of Two Cases and Clinical Considerations 91
Radioterapia ("extended field") versus chemioterapia (MOPP) nel trattamento del m.di Hodgkin (stadio patologico I-IIA): risultati a 10 anni di uno studio prospettico randomizzato italiano 91
In haematopoietic SCT for acute leukemia TBI impacts on relapse but not survival: results of a multicentre observational study. 91
Cetuximab and Radiation Therapy in Head and Neck Cancer 91
Radiotherapy in low-grade glioma adult patients: a retrospective survival and neurocognitive toxicity analysis. 90
Radical radiotherapy of bladder cancer retrospective analysis of a series of 459 patients treated in an Italian Institution 89
Limited-stage small-cell lung cancer treated with early chemo-radiotherapy: the impact of effective chemotherapy. 89
Reliability of prostate-specific antigen-marker in determining biochemical failure during the first 2 years after external beam radiation therapy and hormone therapy in patients with non-operated prostate cancer. 89
GUROPA survey: genito-urinary radiation oncology prescription attitudes 89
COVID-19 Outbreak and Cancer Radiotherapy Disruption in Lombardy, Northern Italy 89
The risk of second malignant tumors and its consequences for the overall survival of Hodgkin's disease patients and for the choice of their treatment at presentation: analysis of a series of 1524 cases consecutively treated at the Florence University Hospital 88
Gene expression profiling to improve prognostic characterization of olfactory neuroblastoma and to define new targetable pathways 88
Late computed tomography scan response improvement and gallium scintigraphy evaluation as on-treatment prognostic parameters to tailor treatment intensity in patients with Hodgkin's lymphoma. A prospective phase II study. 87
The updated ESTRO core curricula 2011 for clinicians, medical physicists and RTTs in radiotherapy/radiation oncology. 87
Exploring the role of enzalutamide in combination with radiation therapy: An in vitro study 87
Combination of novel systemic agents and radiotherapy for solid tumors – part I: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment efficacy 87
Consensus statements on ablative radiotherapy for oligometastatic prostate cancer: A position paper of Italian Association of Radiotherapy and Clinical Oncology (AIRO) 87
Chordoma- Natural history, treatment and prognosis. The Florence Radiotherapy Department experience and a critical review of the literature 86
Radical radiotherapy for bladder cancer: retrospective analysis of a series of 459 patients treated in an Italian institution. 86
Two months of radiation oncology in the heart of Italian “red zone” during COVID-19 pandemic: paving a safe path over thin ice 86
Long term nervous system damage from radiation of the spinal cord: an electrophysiological study 85
Comparison of the conventional "box" technique with two different "conformal" beam arrangements for prostate cancer treatment 85
Results of radiotherapy of prostate cancer: the Florence experience 85
Radiotherapy in case of locally advanced prostate cancer: long-term follow-up in 223 patients 85
"CHEMOTHERAPY VERSUS RADIOTHERAPY IN EARLY-STAGE HODGKIN'S DISEASE: EVIDENCE OF A MORE DIFFICULT RESCUE FOR PATIENTS RELAPSED AFTER CHEMOTHERAPY" 84
Radical radiotherapy for early glottic cancer: Results in a series of 1087 patients from two Italian radiation oncology centers. II. The case of T2N0 disease. 84
Duration of androgen suppression in the treatment of prostate cancer 84
Localized extranodal lymphoma of the head and neck: retrospective analysis of a series of 107 patients from a single institution. 84
Three-dimensional conformal radiotherapy, static intensity-modulated and helical intensity-modulated radiotherapy in glioblastoma. Dosimetric comparison in patients with overlap between target volumes and organs at risk. 84
Totale 11.099
Salva come PNG Salva come JPEG
Categoria #
all - tutte 131.996
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 131.996
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20205.367 0 0 179 688 276 816 589 770 383 1.011 185 470
2020/20214.868 82 527 171 578 187 635 130 584 781 470 523 200
2021/20222.644 143 488 47 104 44 137 113 211 155 305 229 668
2022/20232.483 449 133 72 160 173 638 8 236 305 143 83 83
2023/20242.909 131 48 253 129 119 529 91 116 826 67 81 519
2024/2025124 44 80 0 0 0 0 0 0 0 0 0 0
Totale 25.285